IQV|Analyst Targets
IQV|Company Info
IQV|Insider Trading
IQV|Fundamentals
IQV|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.27 | - | - |
| Q2'26 | $3.24 | $3.15 | -2.9% |
| Q1'26 | $3.04 | $2.90 | -4.7% |
| Q3'25 | $2.98 | $3.00 | +0.8% |
| Q2'25 | $2.77 | $2.81 | +1.4% |
| Q1'25 | $2.63 | $2.70 | +2.6% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $4.4B | - | - |
| Q2'26 | $4.3B | $4.4B | +0.5% |
| Q1'26 | $4.2B | $4.2B | -2.3% |
| Q3'25 | - | $4.1B | - |
| Q2'25 | - | $4.0B | - |
| Q1'25 | - | $3.8B | - |
IQV|Monthly Returns
Market Data
IQV Stock Snapshot
- Market cap
- 43.04B
- P/E ratio
- 31.3
- Day range
- $260.81 – $266.66
- News sentiment
- 79/100 · Bullish
- Analyst target
- $296.47 (+13.2%)
- Consensus
- Buy · 30 analysts
Price is near its 52-week high, and the momentum read backs that positioning up. In Healthcare, names this size usually take direction from sector flows before company-level news.
Reverse DCF
What growth is priced into IQV?
At today's price, IQVIA Holdings Inc. needs to grow free cash flow about 13.1% a year for the next 10 years to justify its valuation at a 8.14% cost of capital. Over its actual history it has compounded free cash flow at 22.0% a year, so the market is asking for 8.9 percentage points below its own delivered rate. On that basis IQV looks priced below what its own growth record supports.
- Implied FCF growth
- 13.1%
- Historical FCF CAGR
- 22.0%
- Growth gap
- -8.9 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 8.14%
- Beta
- 0.89
Behaviour On Record
What IQV's own history says about today's numbers
- Realized volatility (21d)
- 22.2% 42nd pct
- Below its peak
- -7.3%
- vs 200-day average
- +26.4%
- Up days (1y)
- 52%
IQVIA Holdings Inc. is currently running 22.2% annualised volatility over the last 21 sessions. Measured against IQV's own 13 years of daily returns rather than a market-wide average, that is the 42nd percentile — close to its own typical level, against a typical reading of 24.4%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
IQV is trading -7.3% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -20.0%, and the deepest was -49.4% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +26.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 97th percentile — a wider gap than this stock usually carries. Over the past year IQV closed higher on 52% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 14 years of records, IQV finished the month higher 6 of 14 times, with a median return of -0.1% and an average of +0.2%. Its strongest month historically has been July at +9.5% on average, its weakest September at -3.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: IQV has opened more than 2% away from the prior close in 129 of 3,268 sessions (3.9% of the time), with the largest gaps running +7.6% and -16.5%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against IQV's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of IQV's sector?
IQVIA Holdings Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on IQV?
Stifel most recently reiterated its rating on IQVIA Holdings Inc. to Buy on Oct 14, 2026 with a price target of $303 (from $276). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Stifel — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Earnings Release, Scored
What did IQVIA Holdings Inc.'s latest earnings release say?
Most important lines
- 1
To reflect stronger organic revenue growth, and changes in the M&A and foreign exchange impacts, the company is raising its full-year 2026 guidance for revenue to be between $17,275 million and $17,475 million, for Adjusted EBITDA to be between $4,000 million and $4,050 million and for Adjusted Diluted Earnings per Share to be between $12.80 and $13.00.
Guidance raised - 2
The new mid-point of the revenue growth guidance is 6.5% versus the prior guidance of 5.8%, reflecting approximately 100 basis points higher organic revenue growth, and approximately 50 basis points higher contribution from M&A offset by approximately 80 basis points unfavorable change in foreign exchange impact, all versus prior guidance.
Guidance raisedNew this quarter - 3
Revenue $4,368 million, up 8.7% year-over-year
New this quarter
Peers & ETF holders
IQV peers & ETF holders
Diagnostics & ResearchMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 19,650,532 | 11.90% | $4.43B | 2026-01-29 |
| BlackRock, Inc. | ▼ Sell | 14,549,693 | 8.81% | $2.81B | 2026-08-07 |
| Harris Associates L P | ▲ Buy | 12,183,830 | 7.38% | $2.35B | 2026-08-14 |
| JPMorgan Chase & Co | ▲ Buy | 6,139,775 | 3.72% | $1.19B | 2026-08-12 |
| Artisan Partners Limited Partnership | ▼ Sell | 4,743,434 | 2.87% | $916.53M | 2026-08-13 |
| Geode Capital Management, LLC | ▼ Sell | 4,454,134 | 2.70% | $857.16M | 2026-08-12 |
| Invesco Ltd. | ▲ Buy | 3,275,141 | 1.98% | $632.82M | 2026-08-14 |
| Morgan Stanley | ▲ Buy | 2,707,252 | 1.64% | $523.10M | 2026-08-13 |
| Norges Bank | ▲ Buy | 2,264,944 | 1.37% | $437.63M | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 1,949,797 | 1.18% | $376.74M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 1,709,161 | 1.04% | $330.24M | 2026-08-13 |
| AQR Capital Management LLC | ▲ Buy | 1,536,874 | 0.93% | $296.95M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 1,643,102 | 1.00% | $280.21M | 2026-08-14 |
| Bank of America Corp | ▼ Sell | 1,219,081 | 0.74% | $235.55M | 2026-08-14 |
| FMR LLC (Fidelity) | ▼ Sell | 1,212,670 | 0.73% | $234.31M | 2026-08-13 |
| Balyasny Asset Management L.P. | ▲ Buy | 700,425 | 0.42% | $135.34M | 2026-08-14 |
| Millennium Management LLC | ▲ Buy | 516,724 | 0.31% | $99.84M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 466,234 | 0.28% | $90.09M | 2026-08-14 |
| Capital World Investors | ▼ Sell | 316,887 | 0.19% | $61.23M | 2026-08-12 |
| Man Group plc | ▲ Buy | 295,679 | 0.18% | $57.13M | 2026-08-14 |
| Point72 Asset Management, L.P. | ▲ Buy | 279,468 | 0.17% | $54.00M | 2026-08-14 |
| Wells Fargo & Company | ▼ Sell | 229,391 | 0.14% | $44.32M | 2026-08-14 |
| Citadel Advisors LLC | ▼ Sell | 229,366 | 0.14% | $44.32M | 2026-09-02 |
| Citigroup Inc | ▼ Sell | 222,503 | 0.13% | $42.99M | 2026-08-03 |
| Gotham Asset Management, LLC | ▲ Buy | 140,692 | 0.09% | $27.18M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Kevin Hern | House | OK01 | ▼ Sell | $15K - $50K | 2026-09-14 | 2026-09-25 |
| Kevin Hern | House | OK01 | ▼ Sell | $1K - $15K | 2026-09-08 | 2026-09-25 |
| Kevin Hern | House | OK01 | ▼ Sell | $1K - $15K | 2026-09-03 | 2026-09-25 |
| Kevin Hern | House | OK01 | ▼ Sell | $50K - $100K | 2026-03-16 | 2026-04-03 |
| John Boozman | Senate | AR | ▼ Sell | $1K - $15K | 2025-10-02 | 2025-11-15 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-05-15 | 2025-05-31 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $15K - $50K | 2025-04-08 | 2025-05-08 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-02-25 | 2025-03-27 |
| John F. Reed | Senate | RI | ▼ Sell | $1K - $15K | 2019-02-28 | 2019-03-18 |
| John F. Reed | Senate | RI | ▼ Sell | $1K - $15K | 2019-02-04 | 2019-03-01 |
| John F. Reed | Senate | RI | ▼ Sell | $1K - $15K | 2018-03-09 | 2018-03-12 |